Release date: 2007-03-26
In a groundbreaking development, the United Kingdom has introduced a new type of mouthwash test designed to help identify the risk of breast cancer at an early stage. This innovative method is particularly beneficial for women who may develop breast cancer before menopause, as it offers a non-invasive and convenient way to assess their genetic predisposition to the disease.
The test works by having a woman swish a special mouthwash in her mouth for 30 seconds and then spit it into a container. This process collects DNA samples from the oral cells, which are then analyzed in a laboratory to determine the likelihood of developing breast cancer. By examining genetic markers related to estrogen metabolism, the test helps identify individuals who may be at higher risk.
While this test provides valuable insights, experts emphasize that it should not replace regular health check-ups or self-examinations. Women are still encouraged to remain vigilant about any changes in their breasts and seek medical advice promptly if they notice anything unusual. Early detection remains one of the most critical factors in successfully treating breast cancer.
The test specifically targets non-hereditary cases of breast cancer, focusing on the activity of 10 key enzymes involved in breaking down estrogen. Since high levels of estrogen have been linked to an increased risk of breast cancer, monitoring these enzymes can provide important clues about a woman’s susceptibility.
Breast cancer remains one of the most common and serious forms of cancer affecting women worldwide. It is estimated that over one million women are diagnosed with the condition each year. Although rare, men can also develop breast cancer, but their risk is significantly lower—approximately 100 times less than that of women.
As research continues to advance, tools like this mouthwash test represent a promising step forward in making early cancer detection more accessible and less invasive. With ongoing improvements in medical technology, the future holds great potential for more effective and personalized approaches to cancer prevention and treatment.
Guangzhou Fuerle Health Technology Co., Ltd , https://www.fuerlegroup.com